Skip to content

Visualization of regional lung ventilation using Electrical Impedance Tomography (EIT)

Visualization of regional lung ventilation using Electrical Impedance Tomography (EIT) - Visualizing lung ventilation with EIT (Elektrical Impedance Tomography)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42254
Enrollment
16
Registered
2015-04-16
Start date
2015-05-26
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilation in healthy lungs

Interventions

Electrical Impedance Tomography (EIT)
Regionalization

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Group 1 (healthy subjects): 1. Age 18-65 years 2. BMI 18.4 * 24.9 kg/m2 3. Gender: both male and female

Exclusion criteria

Exclusion criteria: Group 1 (healthy subjects): 1. Conditions that interfere with respiration e.g. - asthma - COPD - hyperventilation - Previous claustrophobic conditions - Recent (

Design outcomes

Primary

MeasureTime frame
1) The main endpoint of this study is to gain insight in the possibilities of the PulmoVista system to visualize lung ventilation in healthy subjects aged 18-65. 2) Another main endpoint is the effect of different positions on lung ventilation. To this end, healthy subject will be placed in different positions (specified below) and regional ventilation will be assessed using the PulmoVista system 3) The effect of applying CPAP for a short time period will be tested on healthy subjects.

Secondary

MeasureTime frame
1) The number of adverse and serious adverse events will be documented, although it is not expected to occur in this study. 2) Experience of operators working with this technique. This will be qualitative data and the data will be used to correctly interpret data and to set-up studies in the future.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)